Health Care & Life Sciences » Pharmaceuticals | Nuvo Pharmaceuticals Inc.

Nuvo Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
10,378.00
38,590.00
8,328.00
7,409.00
1,581.00
6,153
Depreciation, Depletion & Amortization
1,338.00
715.00
276.00
233.00
258.00
2,493
Other Funds
-
-
-
35,016.00
-
3,691
Funds from Operations
2,412.00
2,873.00
7,291.00
6,361.00
2,833.00
7,576
Changes in Working Capital
677.00
5,513.00
3,341.00
2,493.00
1,658.00
4,061
Net Operating Cash Flow
1,735.00
2,640.00
10,632.00
3,868.00
4,491.00
3,515
Capital Expenditures
229.00
224.00
332.00
368.00
2,622.00
Sale of Fixed Assets & Businesses
-
378.00
-
-
-
Purchase/Sale of Investments
-
10,000.00
10,000.00
8,000.00
6,000.00
Net Investing Cash Flow
229.00
33,708.00
9,668.00
8,368.00
5,403.00
Issuance/Reduction of Debt, Net
2,118.00
5,220.00
188.00
55.00
2.00
Net Financing Cash Flow
2,195.00
815.00
827.00
34,708.00
5.00
Net Change in Cash
472.00
35,654.00
405.00
39,091.00
1,191.00
Free Cash Flow
1,964.00
2,416.00
10,964.00
3,500.00
1,885.00
Net Assets from Acquisitions
-
-
-
-
8,781.00
Other Sources
-
43,554.00
-
-
-
Change in Capital Stock
77.00
4,405.00
1,015.00
363.00
7.00
Exchange Rate Effect
241.00
121.00
542.00
117.00
284.00

About Nuvo Pharmaceuticals

View Profile
Address
6733 Mississauga Road
Mississauga Ontario L5N 6J5
Canada
Employees -
Website http://www.nuvopharmaceuticals.com
Updated 07/08/2019
Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through two business units: Topical Products and Technology Group and the Immunology Group. The Topical Products and Technology Group business unit has four U.